Idun Medica A/S
Public limited companyCVR 45262235Randers NØActive
Idun Medica A/S is a public limited company, based in Randers NØ, active in manufacture of basic pharmaceutical products, founded in 2024. The company is new and has been registered for 2 years. The latest net result (2025) was DKK 0. 8 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesEmployees
- 22 more employees than a year earlier: 27 (07/2026) against 5 (07/2025).
Management and owners, last 24 months
- New in management: Søren Kjær (director, 06/12/2024), Søren Kjær (board member, 06/12/2024) and Jens Amstrup (board member, 10/06/2026) (+5).
- Stepped down: Jakob Hedemann Hansen (chair of the board, 10/06/2026) and Scott Nilsen Hylen (board member, 10/06/2026).
- New owners registered: Niels Hougaard (16/06/2026), M.rosager Holding ApS (16/06/2026) and MS Kjær Holding ApS (16/06/2026) (+5).
- No longer registered as owner: Jens Hedemann Mortensen (20/12/2024), Jhm Holding A/S (15/06/2026) and Jhm Holding A/S (29/06/2026).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | 1,540 | – |
| Net profit | 0 | – |
| Total assets | 8,056 | – |
| Equity | 800 | – |
| Liabilities | 7,256 | – |
| Cash and cash equivalents | 100 | – |
| Average number of employees | 4 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLow equity ratio
Equity makes up 10% of total assets in 2025.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 06/12/2024 – 31/12/2025 | 25/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
14 companies in the databaseComparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.
Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 9,317of 9,892 Better than 6% | No. 7,770of 9,922 Better than 22% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 6,976of 16,614 Better than 58% | No. 4,486of 16,661 Better than 73% |
| All companies of type A/S18,025 companies in the comparison | No. 15,114of 17,786 Better than 15% | No. 16,253of 18,024 Better than 10% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of basic pharmaceutical products- Idun Medica A/SDKK 1.5m
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Idun Medica A/SDKK 0
- Xellia Pharmaceuticals ApSDKK 213.7m
- Glycom Manufacturing A/SDKK 69.2m
- Idun Medica A/SDKK 800k
- Xellia Pharmaceuticals ApSDKK 404.6m
- Glycom Manufacturing A/SDKK 577.7m
- Idun Medica A/S27
- Xellia Pharmaceuticals ApS458
- Glycom Manufacturing A/S116
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Niels Hougaard20%
- M.rosager Holding ApS20%
- MS Kjær Holding ApS10%
- EASK Holding ApS10%
- Jens Hedemann Mortensen33.33%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Søren Kjær | Director | 06/12/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Søren Kjær | Board member | 06/12/2024 |
| Jens Amstrup | Board member | 10/06/2026 |
| Morten Erik Friis | Board member | 10/06/2026 |
| Michelle Hedemann Løvstad Mortensen | Board member | 10/06/2026 |
| Rune Schrader Hougaard | Board member | 10/06/2026 |
- Founders
- Jens Hedemann Mortensen
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Jakob Hedemann Hansen | Chair of the board | 06/12/2024 | 10/06/2026 |
| Scott Nilsen Hylen | Board member | 06/12/2024 | 10/06/2026 |
Signing rule: Selskabet tegnes af direktøren i forening med ét bestyrelsesmedlem.
Address and production units
1 active production unitsNyholmsvej 4
8930 Randers NØ
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Idun Medica A/S | Nyholmsvej 4, 8930 Randers NØ | 26 | 1030901661 |
Purpose
Selskabets formål er produktion og salg af medicinsk canabis og anden hermed efter bestyrelsens skøn forenelig virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
23 registered events202615 changesownership 8 · accounts 1 · management 6
- OwnershipJens Hedemann Mortensen registered as owner (33.33%)
- OwnershipJHM HOLDING A/S is no longer registered as owner
- AccountsAnnual report for 2025 published
- OwnershipJHM HOLDING A/S registered as owner (33.33%)
- OwnershipNiels Hougaard registered as owner (20%)
- OwnershipM.ROSAGER HOLDING ApS registered as owner (20%)
- OwnershipMS Kjær Holding ApS registered as owner (10%)
- OwnershipEASK Holding ApS registered as owner (10%)
- OwnershipJHM HOLDING A/S is no longer registered as owner
- ManagementRune Schrader Hougaard appointed board member
- ManagementJens Amstrup appointed board member
- ManagementMorten Erik Friis appointed board member
- ManagementMichelle Hedemann Løvstad Mortensen appointed board member
- ManagementJakob Hedemann Hansen stepped down as chair of the board
- ManagementScott Nilsen Hylen stepped down as board member
20248 changesownership 3 · founded 1 · management 4
- OwnershipJHM HOLDING A/S registered as owner (100%)
- OwnershipJens Hedemann Mortensen is no longer registered as owner
- FoundedRegistered as Idun Medica A/S
- ManagementJakob Hedemann Hansen appointed chair of the board
- ManagementScott Nilsen Hylen appointed board member
- ManagementSøren Kjær appointed director
- ManagementSøren Kjær appointed board member
- OwnershipJens Hedemann Mortensen registered as owner (100%)
Related companies
Same people in management
- All4Labels Denmark SB ApSvia Jens Hedemann Mortensen
- Tetra Pak Danmark A/Svia Niels Hougaard
- Vulkan Dæk A/Svia Jens Hedemann Mortensen
- Ikonlabel A/S, Brøndbyvia Jens Hedemann Mortensen
- Falby Design ApSvia Jens Amstrup
- Stenocare A/Svia Søren Kjær
Largest in the industry
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Biofac A/SDKK 73.6m
- Zpd A/SDKK 52.7m
- Danipharm A/SDKK 37.6m
- Pharma Medico ApSDKK 32.3m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.